A designer's rendering of the Immune-Path Biotech vaccine industrialization base. [Photo/WeChat account: snd-szgxqfb]
Immune-Path Biotech is an innovative biotechnology company based in Suzhou New District. It was founded in 2017 by a team of national specially-invited experts, as well as domestic and overseas pharmaceutical companies.
Immune-Path Biotech has been focusing on the research and development of new-type preventative and therapeutic vaccines for humans, as well as the industrialization of biomedical products.
The company held a groundbreaking ceremony for its vaccine industrialization base on Jan 25. The two-phase project had a total of 1.2 billion yuan ($185.88 million) in investment. It is expected to generate annual revenue of at most 10 billion yuan and pay 1 billion yuan in taxes. The first phase of the project covers an area of 66,000 square meters.
